Results(113)
DARWIN EU® - Enhanced Preparedness of the DARWIN EU Network for regulatory questions in oncology – DARWIN OncoNet
Croatia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Italy
Netherlands
Norway
Spain
Sweden
United Kingdom
EU PAS number:
EUPAS1000000824
First published:
17/07/2026
Study
Ongoing
DARWIN EU® - Capturing obesity in DARWIN EU
Belgium
Croatia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Italy
Netherlands
Norway
Portugal
Spain
Sweden
United Kingdom
EU PAS number:
EUPAS1000000820
First published:
12/05/2026
Study
Planned
DARWIN EU® - Enabling pregnancy and mother-child research in DARWIN EU® Data Network - PeriNet
Croatia
Denmark
Finland
France
Germany
Hungary
Netherlands
Norway
Portugal
Spain
Sweden
United Kingdom
EU PAS number:
EUPAS1000000812
First published:
04/09/2026
Study
Finalised
DARWIN EU® - Feasibility of studies on early (pre-symptomatic) stages of type 1 diabetes mellitus in the DARWIN EU® network
Denmark
Finland
France
Hungary
Netherlands
Spain
EU PAS number:
EUPAS1000000756
First published:
08/04/2026
Study
Finalised
DARWIN EU® - Population demographics and disease frequency across the DARWIN EU® network
Belgium
Croatia
Estonia
France
Germany
Greece
Hungary
Netherlands
Norway
Portugal
Spain
Sweden
United Kingdom
EU PAS number:
EUPAS1000000962
First published:
08/04/2026
Study
Ongoing
DARWIN EU® - Azathioprine - user characteristics
Germany
Netherlands
Spain
United Kingdom
EU PAS number:
EUPAS1000000322
First published:
14/08/2026
Study
Finalised
DARWIN EU® - Cancer incidence during pregnancy
Norway
Spain
United Kingdom
EU PAS number:
EUPAS1000001059
First published:
26/08/2026
Study
Ongoing
DARWIN EU® – Prevalence of selected cancers
Croatia
Denmark
Germany
Netherlands
Norway
EU PAS number:
EUPAS1000000715
First published:
20/08/2026
Study
Finalised
DARWIN EU® - Characterisation of aliskiren users
Denmark
Netherlands
Spain
United Kingdom
EU PAS number:
EUPAS1000000768
First published:
27/01/2026
Study
Finalised
DARWIN EU® – Drug Utilisation Study of terbinafine-containing products
Croatia
Denmark
Finland
Germany
Spain
United Kingdom
EU PAS number:
EUPAS1000000790
First published:
20/08/2026
Study
Finalised
DARWIN EU® - Characterising interstitial lung disease in Europe
France
Germany
Spain
United Kingdom
EU PAS number:
EUPAS1000000172
First published:
11/08/2026
Study
Ongoing
DARWIN EU® - Prescription trends of ketamine and esketamine
Denmark
Finland
France
Germany
Spain
United Kingdom
EU PAS number:
EUPAS1000000436
First published:
22/07/2026
Study
Finalised
DARWIN EU® - Pregnancies amongst statin users with familial hypercholesterolaemia
Finland
Spain
United Kingdom
United States
EU PAS number:
EUPAS1000001100
First published:
27/08/2026
Study
Planned
DARWIN EU® - Use of antiretroviral therapies in paediatric patients
Germany
Norway
Spain
United Kingdom
EU PAS number:
EUPAS1000000545
First published:
25/08/2026
Study
Finalised
DARWIN EU® - Encephalitis risk in pediatric varicella vaccine recipients
Denmark
Finland
Norway
Spain
EU PAS number:
EUPAS1000000813
First published:
21/08/2026
Study
Finalised
DARWIN EU® Characterization of patients with chronic hepatitis B and C
Estonia
France
Germany
Netherlands
Spain
United Kingdom
EU PAS number:
EUPAS107650
First published:
20/08/2026
Study
Finalised
DARWIN EU® Prevalence of rare blood cancers in Europe
Belgium
Germany
Netherlands
Spain
United Kingdom
EU PAS number:
EUPAS50800
First published:
20/08/2026
Study
Finalised
DARWIN EU® - RR1 Drug Utilisation Study of prescription opioids
Belgium
Denmark
Estonia
France
Netherlands
Norway
Spain
EU PAS number:
EUPAS1000000479
First published:
11/08/2026
Study
Finalised
DARWIN EU® - CGRP antagonists - Treatment patterns and users characteristics
Croatia
Finland
Germany
Spain
EU PAS number:
EUPAS1000000240
First published:
11/08/2026
Study
Finalised
DARWIN EU® - Alzheimer’s Disease: Incidence, Prevalence, and Individuals' Characteristics
Croatia
Denmark
Germany
Netherlands
United Kingdom
EU PAS number:
EUPAS1000000826
First published:
06/08/2026
Study
Finalised
DARWIN EU® - Assessment of immunoglobulin use in clinical practice
Denmark
France
Germany
United Kingdom
EU PAS number:
EUPAS1000000823
First published:
01/07/2026
Study
Finalised
DARWIN EU® - Drug utilisation study of intramuscular depot olanzapine
Croatia
Denmark
Germany
Hungary
Sweden
EU PAS number:
EUPAS1000000980
First published:
22/05/2026
Study
Ongoing
DARWIN EU® - RR2 Drug utilisation study of prescription opioids
Croatia
Finland
Germany
Hungary
Italy
Portugal
Sweden
EU PAS number:
EUPAS1000000615
First published:
23/01/2026
Study
Finalised
DARWIN EU® - Drug Utilisation Study on GLP-1 Receptor Agonists
Belgium
Germany
Netherlands
Spain
United Kingdom
EU PAS number:
EUPAS1000000223
First published:
19/12/2024
Study
Finalised
DARWIN EU® - Capturing suicidality and depression related variables in databases
Denmark
Estonia
Finland
France
Germany
Greece
Netherlands
Norway
Portugal
Spain
Sweden
United Kingdom
EU PAS number:
EUPAS1000000825
First published:
21/08/2026
Study
Finalised
DARWIN EU® Monitoring prescription of essential medicines administered in ICU
France
Portugal
Spain
EU PAS number:
EUPAS1000000089
First published:
14/08/2026
Study
Finalised
DARWIN EU® - Monitoring prescription of essential medicines administered in ICU
Finland
France
Greece
Hungary
Portugal
Spain
EU PAS number:
EUPAS1000000534
First published:
14/08/2026
Study
Finalised
DARWIN EU® - Clozapine and the incidence of agranulocytosis over time
Croatia
Denmark
Finland
Germany
Spain
EU PAS number:
EUPAS1000000549
First published:
11/08/2026
Study
Finalised
DARWIN EU® Use of take-home naloxone for opioid overdose treatment
Belgium
Germany
Spain
United Kingdom
EU PAS number:
EUPAS105644
First published:
07/08/2026
Study
Finalised
DARWIN EU® - Treatment characterisation and post-diagnosis outcomes in Alzheimer’s disease
Croatia
Denmark
Germany
Netherlands
EU PAS number:
EUPAS1000000827
First published:
23/06/2026
Study
Finalised
DARWIN EU® - RR Childhood hypertension and sartans prescribing in children
Croatia
Denmark
Finland
France
Germany
Hungary
Netherlands
Norway
Spain
EU PAS number:
EUPAS1000000714
First published:
19/03/2026
Study
Finalised
DARWIN EU® - Characterisation of individuals with cystic fibrosis in Europe
Croatia
Denmark
France
Germany
United Kingdom
EU PAS number:
EUPAS1000000709
First published:
11/02/2026
Study
Finalised
DARWIN EU® - Suicidality following exposure to doxycycline
Netherlands
Spain
United Kingdom
EU PAS number:
EUPAS1000000280
First published:
14/08/2026
Study
Finalised
DARWIN EU® – Trends in utilisation of Attention-Deficit Hyperactivity Disorder (ADHD) Medications
Belgium
Germany
Netherlands
Spain
United Kingdom
EU PAS number:
EUPAS1000000219
First published:
20/08/2026
Study
Finalised
DARWIN EU® – Trends in utilisation of Attention-Deficit Hyperactivity Disorder (ADHD) Medications
Denmark
Germany
Spain
Sweden
EU PAS number:
EUPAS1000000678
First published:
20/08/2026
Study
Finalised
DARWIN EU® - Drug utilisation study on medicinal use of Pelargonii radix
Belgium
Germany
EU PAS number:
EUPAS1000000150
First published:
11/08/2026
Study
Finalised
DARWIN EU® - Drug utilisation study on medicinal use of cannabis flos
Germany
Netherlands
EU PAS number:
EUPAS1000000228
First published:
11/08/2026
Study
Finalised
DARWIN EU® - RR Characterisation of individuals with cystic fibrosis in Europe
France
Hungary
Italy
Norway
Spain
EU PAS number:
EUPAS1000000710
First published:
03/02/2026
Study
Finalised
DARWIN EU® Drug utilization study of prescription opioids
Belgium
Estonia
France
Germany
Netherlands
Spain
EU PAS number:
EUPAS105641
First published:
13/06/2025
Study
Finalised
DARWIN EU® - Prescription of Common Drugs Before and During Pregnancy in Europe
Norway
Spain
Sweden
United Kingdom
EU PAS number:
EUPAS1000001101
First published:
27/08/2026
Study
Planned
Compare data sources
Compare data sources